The Saudi Arabia clinical nutrition market size is witnessing robust growth due to the increasing prevalence of chronic diseases, an aging population, rising healthcare expenditure, and greater awareness of disease-specific nutritional support. Clinical nutrition products are becoming an integral part of patient care across hospitals, long-term care facilities, and home healthcare settings. The market is further supported by government initiatives to strengthen healthcare infrastructure, expand specialized medical services, and promote preventive healthcare under Vision 2030. Growing demand for enteral and parenteral nutrition, coupled with continuous product innovation, is creating new opportunities for manufacturers and healthcare providers.

Saudi Arabia clinical nutrition market size reached USD 592.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,040.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.45% during 2026-2034.

How AI is Reshaping the Future of Saudi Arabia Clinical Nutrition Market?

Artificial intelligence is transforming clinical nutrition by improving personalized patient care, hospital nutrition management, and treatment outcomes across Saudi Arabia.

• AI-powered clinical decision support systems help healthcare professionals recommend personalized nutrition plans based on patient conditions, laboratory results, and medical history.
• Hospitals are utilizing AI analytics to identify patients at risk of malnutrition, enabling early nutritional intervention and reducing complications associated with chronic diseases.
• AI-driven remote patient monitoring supports home enteral nutrition programs by tracking nutritional intake, treatment adherence, and recovery progress in real time.
• Pharmaceutical and nutrition companies are applying AI in research and product development to formulate disease-specific nutritional supplements for diabetes, oncology, renal disorders, and critical care patients.
• AI-enhanced supply chain management improves inventory forecasting for hospitals and pharmacies, minimizing shortages of essential clinical nutrition products while reducing operational costs.
• Digital healthcare platforms integrated with AI are improving patient engagement through personalized dietary recommendations, medication reminders, and nutrition counseling.

Grab a sample PDF of this report:
https://www.imarcgroup.com/saudi-arabia-clinical-nutrition-market/requestsample

Market Growth Factors

Saudi Arabia’s increasing burden of lifestyle-related diseases is significantly driving demand for clinical nutrition products. According to the International Diabetes Federation, Saudi Arabia ranks among the countries with the highest diabetes prevalence globally, with millions of adults living with diabetes. Rising cases of obesity, cardiovascular diseases, kidney disorders, and cancer are increasing the need for specialized nutritional therapies that improve treatment outcomes and patient recovery. Hospitals are increasingly incorporating medical nutrition into comprehensive disease management protocols.

Government investment in healthcare modernization continues to strengthen the clinical nutrition sector. Vision 2030 aims to improve healthcare quality, expand private sector participation, and increase digital health adoption throughout the Kingdom. The Ministry of Health continues to promote preventive healthcare, early diagnosis, and integrated patient care. Saudi Arabia allocates a significant share of its national budget to healthcare, supporting new hospitals, specialized treatment centers, intensive care units, and long-term care facilities that require advanced clinical nutrition products.

The growing elderly population and expansion of home healthcare services are creating additional opportunities for the market. Older adults frequently require nutritional support for age-related conditions, postoperative recovery, and chronic disease management. Increasing awareness among healthcare professionals regarding early nutritional intervention, combined with improved availability of specialized enteral and parenteral nutrition products, continues to support market expansion across hospitals, rehabilitation centers, and homecare environments.

Market Segmentation

Product Type Insights

• Infant Nutrition
• Enteral Nutrition
• Parenteral Nutrition

Route of Administration Insights

• Oral
• Enteral Tube Feeding
• Intravenous

Application Insights

• Cancer
• Gastrointestinal Diseases
• Neurological Diseases
• Diabetes
• Critical Care
• Others

End User Insights

• Hospitals
• Clinics
• Home Care Settings
• Long-Term Care Facilities

Regional Insights

• Riyadh
• Jeddah
• Makkah
• Madinah
• Eastern Province
• Rest of Saudi Arabia

Recent Development & News

• February 2024: The Ministry of Health expanded digital nutrition and preventive healthcare initiatives through virtual healthcare services, improving access to nutritional counseling for patients with chronic diseases.
• September 2024: Danone announced continued expansion of its specialized medical nutrition portfolio across the Middle East, including Saudi Arabia, with greater emphasis on hospital nutrition and pediatric clinical nutrition solutions.
• April 2025: Nestlé Health Science strengthened collaborations with healthcare institutions across the Gulf region by expanding education programs for healthcare professionals focused on disease-related nutrition management.
• August 2025: Fresenius Kabi introduced additional clinical nutrition solutions across regional healthcare markets to support intensive care, oncology, and home enteral nutrition patients, strengthening product availability within Saudi Arabia.
• March 2026: Saudi Arabia’s healthcare sector continued expanding hospital capacity and specialized treatment centers under Vision 2030, creating increased demand for enteral and parenteral nutrition products across public and private healthcare facilities.
• June 2026: Healthcare conferences held in Riyadh highlighted the growing role of precision nutrition, AI-enabled clinical decision support, and personalized medical nutrition in improving patient outcomes across chronic disease management.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious organizations create lasting impact. The company provides a comprehensive portfolio of market research and consulting services, including market entry strategy, industry analysis, feasibility studies, company incorporation support, factory setup assistance, regulatory advisory, competitive benchmarking, pricing analysis, procurement research, branding strategy, and business expansion consulting.

Contact Us

IMARC Group

134 N 4th St., Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel: +91 120 433 0800

United States: +1 201 971 6302